Nadja West joins our podcast to discuss her experience leading soldiers through a health crisis with trust and empathy.
Chinese platforms and service providers are experiencing a spike in tech adoption and utilization amidst the pandemic.
Part 2: Healthcare’s ‘Corona Effect’
Ten expectations regarding voluntary offerings, telemedicine, direct contracting, and more as COVID-19 unfolds.
It’s senior leadership’s job — including board members — to mitigate the effects of this pandemic.
Evaluating healthcare workforce supply and demand.
A one-size-fits-all SDOH approach isn't the answer. Yet it's the industry norm.
An analysis of annual premiums by federal poverty level.
Physicians are best positioned to curtail the $265 billion wasted annually on unneeded care.
Oliver Wyman Actuarial Consulting analyzes what happens after manufacturer costs for brand drugs change hands.
Based on our analysis recently featured in the Wall Street Journal, the prevalence of no cost bronze coverage has increased significantly for 2018.